Skip to main content
Premium Trial:

Request an Annual Quote

Intelligent Bio-Systems Lands $600K SBIR from NIAID to Develop Sequence-Based HIV Test

NEW YORK (GenomeWeb News) - Intelligent Bio-Systems has received a $600,000, two-year Small Business Innovation Research grant from the National Institute of Allergy and Infectious Disease to develop a DNA-sequencing-based test that would detect and quantify drug-resistant variants of HIV-1, the company said today.
 
IBS licenses its sequencing-by-synthesis technology through a deal with the Columbia Genome Center at Columbia University. As GenomeWeb News reported in December the company is developing its sequencing platform and expects to launch it commercially sometime in 2008.
 
Although current methods of drug-resistant genotyping can detect this virus only above 20 percent abundance, IBS’ VP of R&D, Jerzy Olejnik, said the company's sequencing technology can detect the virus at 1 percent or less abundance.
 
Detecting drug resistance at lower levels could enhance the ability of physicians to plan their treatment regimens, the company said.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.